Application no. and date | 19196267.9 (espacenet) (Federated) (European Patent Register), 20040614 | Patent/reg. no. and date | DK/EP 3604537, 20211208 | Publication date | 20200205 | Priority no. and date | EP 03013296, 20030613, US 479354 P, 20030618, EP 04002374, 20040203 | EP pub. no. and date |
EP 3604537 20200205 | Effective date | | Applicant/owner | Alnylam Europe AG, Fritz-Hornschuch-Strasse 9
95326 Kulmbach, DE | Applicant ref. no. | 1621073 | Inventor | JOHN, Matthias, Kapellenstrasse 12
96103 Hallstadt, DE, VORNLOCHER, Hans-Peter, Lise-Meitner-Platz 4
95448 Bayreuth, DE, LIMMER, Stefan, Am Buttergraben 11
95326 Kulmbach, DE, Woppmann, Claudia, Lerchenweg 9
95494 Gesees, DE, Hadwiger, Philipp, Schlesierstrasse 6
96264 Altenkunstadt, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | A61K 31/713 (2006.01) , A61P 35/00 (2006.01) , A61P 37/00 (2006.01) , A61P 5/00 (2006.01) , A61P 7/00 (2006.01) , C12N 15/11 (2006.01) , C12N 15/113 (2010.01) | Title | Dobbeltstrenget ribonukleinsyre med forøget effektivitet i en organisme | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|